Table 1.
Patient characteristics in the LVH and control groups
| Item | LVH (n=30) | Control (n=30) | P-value |
|---|---|---|---|
| Age (years) |
66.0±15.7 |
62.9±14.5 |
0.4321 |
| Male (%) |
18 (60%) |
17 (56%) |
0.5893 |
| Height (cm) |
160.6±9.2 |
161.6±9.6 |
0.6551 |
| Weight (kg) |
58.9±11.6 |
59.2±11.3 |
0.9121 |
| BMI (kg/m2) |
22.7±3.4 |
22.5±2.7 |
0.7824 |
| Systolic blood pressure (mmHg) |
133.3±13.4 |
122.7±12.3 |
0.1012 |
| Diastolic blood pressure (mmHg) |
75.6±10.9 |
69.4±10.4 |
0.0516 |
| Hypertension |
30 (100%) |
5 (16%) |
<0.0001 |
| Diabetes mellitus |
5 (16%) |
4 (13%) |
0.5892 |
| Hyperlipidemia | 12 (40%) | 8 (27%) | 0.1257 |
Data are shown as a number (%) or mean ± S.D. LVH = left ventricular hypertrophy; BMI = body mass index. There were no significant differences in mean age, gender, height, weight, BMI, systolic and diastolic blood pressure between the two groups. Frequencies of diabetes mellitus and hyperlipidemia did not differ significantly between the two groups, but the frequency of hypertension in the LVH group was significantly higher than that in the control group.